Immune silencing is driven by 9p regional genetic loss dictating immune checkpoint inhibitor resistance - Scott Lippman, MD, UCSD

Scott Lippman, MD
University of California, San Diego
Director, Moores Cancer Center
Senior Associate Dean and Associate Vice Chancellor, Cancer Research and Care 
Distinguished Professor of Medicine
Chugai Pharmaceutical Chair in Cancer Research 

Join us in-person or via Zoom.
RSVP HERE!
Lunch is available to in-person attendees.

DGSOM Theme: Cancer Research Theme

Co-sponsored by the UCLA David Geffen School of Medicine Themes

For additional information, please contact:
ctsiseminar@mednet.ucla.edu